ENDRA Life Sciences Inc.
NDRA
$3.86
$0.29188.19%
| 09/30/2024 | 06/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -52.82% | -12.91% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -32.36% | -19.77% | |||
| Operating Income | 32.36% | 19.77% | |||
| Income Before Tax | -5.60% | 19.69% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -5.60% | 19.69% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -5.60% | 19.69% | |||
| EBIT | 32.36% | 19.77% | |||
| EBITDA | 32.61% | 19.64% | |||
| EPS Basic | 93.33% | -- | |||
| Normalized Basic EPS | 93.33% | -- | |||
| EPS Diluted | 93.33% | -- | |||
| Normalized Diluted EPS | 93.33% | -- | |||
| Average Basic Shares Outstanding | 1,482.05% | -- | |||
| Average Diluted Shares Outstanding | 1,482.05% | -- | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||
